IN2013MU03613A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03613A
IN2013MU03613A IN3613MU2013A IN2013MU03613A IN 2013MU03613 A IN2013MU03613 A IN 2013MU03613A IN 3613MU2013 A IN3613MU2013 A IN 3613MU2013A IN 2013MU03613 A IN2013MU03613 A IN 2013MU03613A
Authority
IN
India
Prior art keywords
pemetrexed
less
oxygen less
2ppm
ready
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Mandal Jayanta
Pareshbhai Mehta Sandip
Original Assignee
Ftf Pharma Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ftf Pharma Private Ltd filed Critical Ftf Pharma Private Ltd
Priority to IN3613MU2013 priority Critical patent/IN2013MU03613A/en
Publication of IN2013MU03613A publication Critical patent/IN2013MU03613A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3613MU2013 2013-11-18 2013-11-18 IN2013MU03613A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3613MU2013 IN2013MU03613A (es) 2013-11-18 2013-11-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3613MU2013 IN2013MU03613A (es) 2013-11-18 2013-11-18

Publications (1)

Publication Number Publication Date
IN2013MU03613A true IN2013MU03613A (es) 2015-07-31

Family

ID=54397601

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3613MU2013 IN2013MU03613A (es) 2013-11-18 2013-11-18

Country Status (1)

Country Link
IN (1) IN2013MU03613A (es)

Similar Documents

Publication Publication Date Title
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MX2015016983A (es) Moduladores del transporte nuclear y usos de los mismos.
MD20170016A2 (ro) Compuşi aminopirimidinici ca inhibitori JAK
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
NZ760790A (en) Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
NZ720478A (en) Autotaxin inhibitor compounds
PH12015501753A1 (en) Enhanced stability of novel liquid compositions
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
MD20140072A2 (ro) Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
PH12018500377A1 (en) Novel annelated benzamides
CL2015002897A1 (es) Inhibidores de bace1
PH12018500378A1 (en) Novel annelated phenoxyacetamides
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MX368635B (es) Compuestos tricíclicos de piperidina.
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
MX363458B (es) Nuevos derivados de tetrazolona.
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE
IN2013MU03613A (es)
MX2017008497A (es) Nuevos compuestos heterocíclicos y su uso tanto en medicina como en cosmética.